BSE · APPL
Aptus Pharma Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,784
of 5,004 stocks
🏆 New peak
▲ 381W
Peak #1,784 · 01 Oct 2026
Operating in Healthcare, Aptus Pharma Limited carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and remains firmly promoter-controlled, with promoters holding 73%.
Market Cap
631.38 Cr
P/E Ratio
118.38
P/B Ratio
27.05
ROE
19.79%
ROCE
29.31%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q4 2024-25 |
|---|---|---|
| Revenue | 32.20 Cr | 14.80 Cr |
| Net Profit | 2.87 Cr | 1.79 Cr |
| EPS | 1.68 | 1.05 |
| Operating Profit | 4.25 Cr | 2.72 Cr |
Shareholding pattern
Promoter
72.89%
Public
27.11%
PUBLIC BREAKDOWN
Individuals
24.06%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 May 2026 | Bonus | Bonus issue 3:2 |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.